Bimatoprost

Bimatoprost on the U.S. market: products, makers and brands

How Bimatoprost appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

15 companies list 28 Bimatoprost product records with the FDA, mostly as eye drops, insert or device, eye ointment; the earliest marketing or approval year on record is 2001. Brand names on the directory include Lumigan, Latisse, Durysta and 1 more; the rest are generics.

Also listed with the FDA, not a patient dose form: Powder (27) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Bimatoprost is used (Medicaid data)

A general measure of how commonly Bimatoprost is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Bimatoprost is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

How commonly is Bimatoprost prescribed? Of the 1,601 medications we measure, Bimatoprost ranks #647 by Medicaid prescriptions — more than 60% of them.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Bimatoprost, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 16 of 52 listed Bimatoprost NDCs with Medicaid activity.

Compare Bimatoprost products

A representative set of FDA-listed product records for Bimatoprost — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 28 of 28 products — FDA National Drug Code Directory. See every product, package size and price: browse all 28 Bimatoprost NDCs →

💵 What Bimatoprost costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Bimatoprost brand names

Bimatoprost is sold under 4 brand names in the FDA directory — Lumigan, Latisse, Durysta, Zolymbus. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Who makes Bimatoprost: manufacturers and labelers

15 companies list Bimatoprost products with the FDA. By number of product records, the largest are Allergan, Inc., Fosun Pharma USA Inc., Gland Pharma Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bimatoprost compared with similar medicines

Medicines in the same class as Bimatoprost that we cover: Carboprost, Dinoprostone. The table compares what the FDA directory records for each — how it is sold, the dose forms on the market, how many companies list it (makers, repackagers and distributors), and the earliest FDA record on file. Same class does not mean interchangeable; your prescriber chooses among them for reasons the label alone does not show.

Source: FDA National Drug Code Directory and Drugs@FDA, as summarized on each medicine's page. A dash means the fact is not on record.